EUVIMEDEUVIMED entdecken
Open Access

Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice

Pei Y Ng, Cheng Zhang, Hu Li, Darren J Baker

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-230465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Pei Y Ng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cellular senescence has been associated with neurodegenerative disease and clearance of senescent cells using genetic or pharmaceutical strategies (senolytics) has demonstrated beneficial effects in mouse models investigating individual disease etiologies of Alzheimer’s disease (AD). However, it has remained unclear if senescent cell clearance in a mouse model exhibiting both plaque and tau pathologies modifies the disease state (3xTg).

Objective

To investigate the effects of senescent cell clearance in the 3xTg mouse model.

Methods

3xTg mice were treated with senolytics (ABT263 (navitoclax; NAVI), a combination of dasatinib and quercetin (D+Q)), or subjected to transgene-mediated removal of p16-expressing cells (via INK-ATTAC).

Results

Senolytic treatments consistently reduced microgliosis and ameliorated both amyloid and tau pathology in 3xTg mice. Using RNA sequencing, we found evidence that synaptic dysfunction and neuroinflammation were attenuated with treatment. These beneficial effects were not observed with short-term senolytic treatment in mice with more advanced disease.

Conclusions

Overall, our results further corroborate the beneficial effects senescent cell clearance could have on AD and highlight the importance of early intervention for the treatment of this debilitating disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesMiceAnimalsSenotherapeuticsMice, TransgenicCellular SenescenceDisease Models, Animaltau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-βcellular senescencetauopathy

Substanzen

Senotherapeuticstau Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Paul F. Glenn Center for Biology of Aging Research, Mayo Clinic, Rochester, MN, USA.
  • The Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
  • Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Ng, P. Y., Zhang, C., Li, H., & Baker, D. J. (2024). Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230465

Vancouver

Ng PY, Zhang C, Li H, Baker DJ. Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-230465

BibTeX
@article{Ng2024,
  author = {Ng, Pei Y and Zhang, Cheng and Li, Hu and Baker, Darren J},
  title = {Senescence Targeting Methods Impact Alzheimer’s Disease Features in 3xTg Mice},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-230465}
}
Kostenlos starten →